US health officials have announced an emergency authorization to change the way the monkeypox vaccine is administered to patients in order to increase access fivefold.
The emergency authorization on Tuesday will allow providers to administer the Jynneos vaccine intradermally – injecting the shot in the upper layer of skin instead of deeper into the tissue.
Health and Human Services Secretary Xavier Becerra said that today’s announcement would take the government’s response ‘to the next level.’
‘Today’s action will allow FDA to exercise additional authorities that may increase availability of vaccines to prevent monkeypox while continuing to ensure the vaccine meets high standards for safety, effectiveness and manufacturing quality,’ Becerra stated.
The new procedure will allow providers to use only one-fifth the amount of a normal dosage, therefore increasing access to the US’s supply of the vaccine.
Recipients would still get the shots in two doses, spaced four weeks apart.
The US has made 1.1 million doses of the Jynneos vaccine available, and over 620,000 have already been shipped to distributors.
The US has a total of 9,493 confirmed cases of monkeypox, according to the latest data from the .
‘It’s safe, it’s effective, and it will significantly scale the volume of vaccine doses available for communities across the country,’ said Robert Fenton, the White House’s monkeypox response coordinator.
The UK and Canada have opted to promote a single-dose vaccine strategy to address their dwindling supplies.
Earlier today, Britain’s National Health Services reported that the country . Officials said the country was likely to run out of the vaccine within 10 to 20 days.
The UK is not scheduled to get another shipment of 100,000 doses until September.
Do you find OkayWap useful? Click here to give us five stars rating!